about
Drug-Induced QT Prolongation as a Result of an Escitalopram Overdose in a Patient with Previously Undiagnosed Congenital Long QT SyndromeThe pharmacokinetics of sertraline in overdose and the effect of activated charcoal.Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.The Toxicology Investigators Consortium (ToxIC) RegistryPredicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose.Mirtazapine overdose is unlikely to cause major toxicity.Escitalopram causes fewer seizures in human overdose than citalopram.QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions.Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Cardiovascular adverse effects of newer antidepressants.CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.How do we assess whether the QT interval is abnormal: myths, formulae and fixed opinion.Antidepressant or Antipsychotic Overdose in the Intensive Care Unit - Identification of Patients at Risk.Do serotonin reuptake inhibitors worsen outcome of patients referred to the emergency department for deliberate multi-drug exposure?Inter-rater reliability of manual QT measurement and prediction of abnormal QT,HR pairs.
P2860
Q33914804-F79D17DC-E37C-48EA-AD70-C0D818A107E3Q35023742-2F502FEB-7132-4634-AC1E-D1995A20467CQ36017378-72C2806A-40BF-4322-BD5C-1591235C8169Q36548841-19E97E17-0F2C-4D7E-BB8F-B3FE995C9958Q37290609-3AF49732-0363-42DB-A4EE-31C2706717DAQ37489869-3EB44B4A-7AEA-4BFF-B4F8-96C5FCEC80A7Q37695292-0BE84C38-7237-4D36-96A2-BE2F108F1E1BQ37727223-F1636974-C15A-4AD5-9CDA-7EBC4EC08301Q38086176-8019A99C-A479-4E8B-8252-D8B531CD7E35Q38092129-62B2039F-7A94-47DE-80AB-EE48BD7211DFQ38205025-79BC0006-6707-4993-B82A-9D13AF548ADCQ38239777-D101BB60-1354-450E-B889-984A1899C171Q41391365-41AAA4A8-31A4-4B8E-9999-631BD930FBE5Q47616480-D937F39A-AA23-4BF1-882E-515778D37BAFQ48226580-AEA6167D-FD0D-4BBC-890D-62C2E6668828Q53061115-D3D60CEF-FF22-4E55-A735-5618ED0D5066
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical and ECG effects of escitalopram overdose.
@ast
Clinical and ECG effects of escitalopram overdose.
@en
Clinical and ECG effects of escitalopram overdose.
@nl
type
label
Clinical and ECG effects of escitalopram overdose.
@ast
Clinical and ECG effects of escitalopram overdose.
@en
Clinical and ECG effects of escitalopram overdose.
@nl
prefLabel
Clinical and ECG effects of escitalopram overdose.
@ast
Clinical and ECG effects of escitalopram overdose.
@en
Clinical and ECG effects of escitalopram overdose.
@nl
P1476
Clinical and ECG effects of escitalopram overdose.
@en
P2093
Freek van Gorp
P304
P356
10.1016/J.ANNEMERGMED.2009.04.016
P407
P577
2009-06-25T00:00:00Z